Aged, 80 years and older
Showing 1 - 25 of >10,000
Sarcopenia Trial in Chengdu (the whole body vibration, resistance training)
Completed
- Sarcopenia
- the whole body vibration
- resistance training
-
Chengdu, Sichuan, ChinaWest China Hospital，Sichuan University
Sep 28, 2021
Sarcopenia Trial in Chengdu (Motor-Assisted and Active Resistive Upper/Lower Extremities Rehabilitation Training System)
Recruiting
- Sarcopenia
- Motor-Assisted and Active Resistive Upper/Lower Extremities Rehabilitation Training System
-
Chengdu, Sichuan, ChinaWest China Hospital，Sichuan University
Sep 13, 2021
Respiratory Syncytial Virus Infections Trial in Fukuoka (RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- RSV_PreF3 Vaccine (GSK3844766A) adjuvanted with AS01B
- Placebo
-
Fukuoka, JapanGSK Investigational Site
Dec 7, 2021
Healthy Volunteers Trial in Saint-Etienne (proprioceptive knee braces, No knee brace)
Not yet recruiting
- Healthy Volunteers
- proprioceptive knee braces
- No knee brace
-
Saint-Etienne, FranceSaint-Etienne Jean Monnet University
Feb 3, 2023
Prevention of COVID-19 Caused by SARS-CoV-2 Trial in Chengdu (randomized, double-blinded, -controlled)
Active, not recruiting
- Prevention of COVID-19 Caused by SARS-CoV-2
- randomized, double-blinded, placebo-controlled
-
Chengdu, ChinaWest China Second University Hospital
Jan 9, 2023
Influenza, Human Trial (Investigational aQIVc, licensed QIV1, licensed QIV2)
Not yet recruiting
- Influenza, Human
- Investigational aQIVc
- +2 more
- (no location specified)
Aug 28, 2023
Prostate Cancer, Radiotherapy Side Effect Trial in Graz (Hypofractionated radiotherapy)
Terminated
- Prostate Cancer
- Radiotherapy Side Effect
- Hypofractionated radiotherapy
-
Graz, AustriaMedical University of Graz
Sep 29, 2022
Knowledges and Use of Cannabidiol in Older Adults
Not yet recruiting
- Aging
- Frailty
- questionnaire
- (no location specified)
Oct 16, 2023
Influenza, Human Trial (Fluarix Tetra Vaccine)
Not yet recruiting
- Influenza, Human
- Fluarix Tetra Vaccine
- (no location specified)
Jan 20, 2023
Coronavirus Trial (Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells), Recombinant novel
Not yet recruiting
- Coronavirus
- Omicron BA.4/5-Delta strain recombinant novel coronavirus protein vaccine (CHO cells)
- Recombinant novel coronavirus protein vaccine (CHO cells)
- (no location specified)
Sep 5, 2023
SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)
Recruiting
- SARS-CoV-2
- SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
- 0.9% sodium chloride solution
-
Islamabad, PakistanSindh Infectious Diseases Hospital & Research Center Dow Univers
Apr 16, 2023
COVID-19 Trial in Kinshasa (EuCorVac-19, ChAdOx1)
Recruiting
- COVID-19
- EuCorVac-19
- ChAdOx1
-
Kinshasa, Congo, The Democratic Republic of theTrial site
Nov 1, 2022
Dermatitis Atopic Trial in Lafayette (Amlitelimab, Placebo, Topical corticosteroids)
Recruiting
- Dermatitis Atopic
- Amlitelimab
- +3 more
-
Lafayette, CaliforniaSunwise Clinical Research Site Number : 8401022
Nov 8, 2023
Lymphoma Trial (pegfilgrastim, rituximab, cyclophosphamide)
Completed
- Lymphoma
- pegfilgrastim
- +5 more
- (no location specified)
Jul 2, 2021
Aged, 80 and Over, Resistance Training Trial in Temuco (Prolonged resistance-type exercise training)
Completed
- Aged, 80 and Over
- Resistance Training
- Prolonged resistance-type exercise training
-
Temuco, ChileDepartment of Internal Medicine, Faculty of Medicine, Universida
Nov 1, 2022
Diphtheria, Tetanus, Pertussis Trial in Xi'an (Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined
Not yet recruiting
- Diphtheria
- +2 more
- Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Aged 6 Years and Older) (Tdcp)
- +2 more
-
Xi'an, Shanxi, ChinaShaanxi Center for Disease Control and Prevention
Sep 25, 2023
Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention Trial in Mechelen (ExPEC9V, Placebo, HD
Recruiting
- Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention
- ExPEC9V
- +2 more
-
Mechelen, BelgiumAz Sint-Maarten
Nov 13, 2023
Elderly Acute Ischaemic Stroke (AIS) Patients
Completed
- Stroke
-
Shanghai, ChinaBoehringer Ingelheim (China) Investment Co., ltd.
Dec 23, 2022
Real Life of New Oral Anticoagulants and Vitamin K Antagonists
Completed
- Atrial Fibrillation
- Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban
- Vitamin K antagonist: warfarin, fluindione, acenocoumarol
-
Paris, FranceAssistance Publique Hôpitaux de Paris
Mar 28, 2022
SARS-CoV-2 Infection Trial (PTX-COVID19-B, Comirnaty®)
Not yet recruiting
- SARS-CoV-2 Infection
- PTX-COVID19-B
- Comirnaty®
- (no location specified)
Sep 7, 2022
Corona Virus Disease 2019(COVID-19) Trial in Chengdu (0.3ml of mRNA vaccine)
Enrolling by invitation
- Corona Virus Disease 2019(COVID-19)
- 0.3ml of mRNA vaccine
-
Chengdu, ChinaWest China Second University Hospital
Oct 3, 2022
SARS-CoV-2 Trial in Chengdu (RBMRNA-176, Placebo)
Active, not recruiting
- SARS-CoV-2
- RBMRNA-176
- Placebo
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023
SARS-CoV-2 Infection Trial (PTX-COVID19-B, Vaxzevria®)
Not yet recruiting
- SARS-CoV-2 Infection
- PTX-COVID19-B
- Vaxzevria®
- (no location specified)
Sep 7, 2022
Pneumonia Trial in Taizhou (23-valent pneumococcal polysaccharide vaccine, pneumococcal vaccine polyvalent)
Completed
- Pneumonia
- 23-valent pneumococcal polysaccharide vaccine
- pneumococcal vaccine polyvalent
-
Taizhou, Jiangsu, ChinaAb&b Biotechnology Co., Ltd.JS
Apr 13, 2023
COVID-19 Trial in Langhorne (BBV152)
Available
- COVID-19
- BBV152
-
Langhorne, PennsylvaniaWoods
Sep 14, 2022